NEWS SUMMARY: MAPFRE, NATURGY. Tariffs marked the weekly performance of stock markets It was a volatile week for global equity markets, awaiting a ceasefire agreement between Ukraine and Russia and in view of the uncertainty generated by the trade war and the possible partial shutdown of the US administration (that was approved in the end by the Senate). In the STOXX 600, most sectors ended with drops, led by Retail and Travel & Leisure vs. the better performance of Utilities and Energy. On th...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: MAPFRE, NATURGY. La política arancelaria marca la evolución semanal de las bolsas Semana de volatilidad en la renta variable global a la espera de un acuerdo de alto el fuego entre Ucrania y Rusia y ante la incertidumbre motivada por la guerra comercial y el posible cierre parcial del Gobierno en EE.UU. (finalmente aprobado por el Senado). En el STOXX 600, mayoría de caídas en los sectores lideradas por Retail y Viajes y Ocio frente al mejor comport...
NEWS SUMMARY: MAPFRE. The Ibex consolidates the 13,250-point level and the DAX hits another record high European stock markets saw a second session of recovery with volatility amid the widening of the German bond and slowdown fears in the US. Thus, in the STOXX 600, cyclical industries such as Autos and Constructions were the best-performing sectors whereas Real Estate and Consumer Goods continued to post the biggest drops. On the macro side, in the euro zone, as expected, the ECB cut the benc...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: MAPFRE. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. El Ibex consolida los 13.250 puntos y el DAX marca otro máximo histórico Segunda sesión de recuperación en Europa pero no exenta de volatilidad entre el repunte del bono alemán y los temo...
NEWS SUMMARY: CELLNEX, MAPFRE, NATURGY. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’24 results to be released over the coming days in Spain. The Ibex tries to hit the 13,000-point level again European stock markets ended mixed in a session marked by the support of European leaders to Ukraine’s president V. Zelenski. In the STOXX 600, Basic Resources and Real Estate were ...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CELLNEX, MAPFRE, NATURGY. EUROPA: AIR LIQUIDE, SECTOR AUTOS. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. El Ibex mantiene su intento de asalto a los 13.000 puntos Las bolsas de Europa terminaron mixtas en una sesión caracterizada por el apo...
Rdos. 4T'24 vs 4T'23: Primas: 6.589 M euros (+5,6% vs +2,0% BS(e) y -1,3% consenso); BDI: 248,0 M euros (+12,0% vs -3,8% BS(e) y +3,9% consenso); Rdos. 2024 vs 2023: Primas: 28.211 M euros (+4,8% vs +4,0% BS(e) y +3,2% consenso); BDI: 902,0 M euros (+30,3% vs +25,3% BS(e) y +27,7% consenso);
>Outperform rating maintained – target price upgraded to € 3.05 (vs € 2.75) - Mapfre posted solid Q3/9M 2024 performances both on the operating front and balance sheet-wise (solvency, etc.), in synch with the new medium-term strategic plan – while it is true that net income fell short of expectations at € 192m (-18% vs cons), the underlying trend remains quite positive with further solid commercial activity, as well as increasingly visible signs of improvement in the ...
>Opinion Surperformance maintenue – OC réhaussé à 3.05 € (vs 2.75 €) - Mapfre délivre au T3/sur 9M 2024 une performance solide à la fois sur l’opérationnel et sur le plan bilanciel (solvabilité…), en phase avec le nouveau plan stratégique MT. Le RN s’établit certes en deçà des attentes à 192 M€ (-18% vs cons) mais l’évolution underlying reste plutôt favorable avec notamment le maintien d’une solide activité commerciale mais aussi de signes de plus en plus visibles d’a...
3Q'24 vs. 3Q'23 Results Premiums: € 6.477 Bn (+2.3% vs. +3.7% BS(e) and +4.8% consensus); Net Profit: € 192.0 M (+25.0% vs. +54.0% BS(e) and +50.5% consensus); 9M'24 vs. 9M'23 Results Premiums: € 21.622 Bn (+4.6% vs. +5.0% BS(e) and +5.3% consensus); Net Profit: € 654.0 M (+39.0% vs. +48.4% BS(e) and +47.2% consensus);
Rdos. 3T'24 vs 3T'23: Primas: 6.477 M euros (+2,3% +3,7% BS(e) y +4,8% consenso); BDI: 192,0 M euros (+25,0% vs +54,0% BS(e) y +50,5% consenso). Rdos. 9meses'24 vs 9meses'23: Primas: 21.622 M euros (+4,6% vs +5,0% BS(e) y +5,3% consenso); BDI: 654,0 M euros (+39,0% vs +48,4% BS(e) y +47,2% consenso).
We hosted our 4th ODDO BHF Iberian Forum on the 1st and 2nd of October 2024, virtually. In total, 63 companies were present. In the following note, we provide some initial feedback from the companies on day 2. - >ACS (=): good operating momentum maintained, Abertis and its dividends on the front page - Atresmedia (=): Q3 should be challenging but outlook reiterated - Befesa (=): zinc prices held up well, offsetting the negative impact of maintenance on Q3 volumes - CaixaBank ...
NEWS SUMMARY: ALMIRALL, CAIXABANK, CELLNEX, MAPFRE. Caution remains due to risk of US recession in a highly volatile week After the week started out with sharp drops (in view of fears of a recession stemming from the US employment data the week before and the rate hike in Japan), the stock markets began to recover. However, towards the end of the week doubts returned, and on Friday, after rising slightly through mid-session, European stock markets lost almost all the ground gained during the af...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.